Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis
- Conditions
- Pancreatitis, Acute
- Registration Number
- NCT03364920
- Lead Sponsor
- Weiqin Li
- Brief Summary
This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Clinical diagnosis of Severe Acute Pancreatitis
- Biliary pancreatitis
- 7 days of the onset
Exclusion Criteria
- Surgical patients
- Serious diseases and infection
- Alcoholic pancreatitis
- Hypertriglyceridemia pancreatitis
- Disorder of Glucolipide Metabolism:diabetes mellitus, hypertriglyceridemia, BMI>30
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mortality up to 28 days The level of serum maresin-1 predicts the severity of severe acute pancreatitis
- Secondary Outcome Measures
Name Time Method The incidence of MODS through study completion, an average of 1 year The level of serum maresin-1 predicts the severity of severe acute pancreatitis
The incidence of IPN through study completion, an average of 1 year The level of serum maresin-1 predicts the severity of severe acute pancreatitis